Scynexis Inc. (SCYX) Stock Moves Down and Here’s Why

Zacks Investment Research (Scynexis Inc.: NASDAQ) shares fell on Wednesday Dec 28 with lower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a downgraded rating.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Zacks Investment Research downgraded shares of Zacks Investment Research (Scynexis Inc.: NASDAQ) from Hold to Sell in a research note to investors today. The company currently has a rating of Sell on the shares. As a means of comparison, a number of other analysts have issued reports on the company in recent days, and Scynexis Inc. has secured a consensus one-year price target of $12.13, higher than the opening price of $3.69, a difference of 33.98 percent. Scynexis Inc. stock has a 52-week high of $6.74. Considerable and crucial digressions in the company’s procedures, future vision or industry can cause downgrades as the analysts believe that the future prospects for the security have diminished from the initial recommendation.

Shares of Zacks Investment Research (Scynexis Inc.: NASDAQ) opened at $3.69 on Tuesday and has traded in a range between, $3.57 and $3.73, and last traded at $3.57, which is a decrease of $0.09 per share or -2.46% from the previous closing price.

Zacks Investment Research (Scynexis Inc.: NASDAQ) currently has a market cap of 85.64M.

Zacks Investment Research (Scynexis Inc.: NASDAQ) Average Daily Trading Volume

The stock’s average daily volume is 538,400 shares out of a total float 22,054,000 and some 59,216 shares crossed the trading desk yesterday, lower than the norm. Investors often use upticks in trading volume to identify substantial volume accumulation or dissemination by institutional investors, so look for trading volume to pick up in the coming days.

While increased trading for one day will not mean much, conversely, a trend of heavy trading volume on the buy side over a series of days or weeks sends a positive cue to market traders that institutions may be moving in, so institutional sponsorship is critical.

Institutional sponsorship commonly refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain teams of analysts that investigate thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

Zacks Investment Research (Scynexis Inc.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By following the activity of these professional investors and how they affect moving averages, traders can make educated trades.

With that in mind, Zacks Investment Research (Scynexis Inc.: NASDAQ) now has a 50-day MA of $3.53 and 200-day MA of $3.07. It has traded in a 52-week range between $1.74 – 6.74 and today’s last price is 47.03%% lower than the 52 week high of $6.74.

Earnings growth is a crucial factor to look at when investing in stocks and investors watch for companies that have increased their earnings by at least 25% for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *